Log In
Print this Print this

NuQ T003

  Manage Alerts
Collapse Summary General Information
Company VolitionRx Ltd.
DescriptionBlood-based test that uses the company's Nucleosomics technology, which identifies and measures circulating nucleosome structures for the presence of epigenetic cancer signals
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsDetect colorectal cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today